Melanoma Diagnostics and Therapeutics Market - Global Outlook and Forecast 2024-2031

Report ID: 1377009 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Melanoma Diagnostics and Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Melanoma Diagnostics and Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Melanoma Diagnostics and Therapeutics Overall Market Size
    2.1 Global Melanoma Diagnostics and Therapeutics Market Size: 2021 VS 2028
    2.2 Global Melanoma Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Melanoma Diagnostics and Therapeutics Players in Global Market
    3.2 Top Global Melanoma Diagnostics and Therapeutics Companies Ranked by Revenue
    3.3 Global Melanoma Diagnostics and Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Melanoma Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Melanoma Diagnostics and Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Melanoma Diagnostics and Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Melanoma Diagnostics and Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Melanoma Diagnostics and Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Melanoma Diagnostics and Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Nodular Melanoma
        4.1.3 Superficial Spreading Melanoma
        4.1.4 Amelanotic Melanoma
        4.1.5 Others
    4.2 By Type - Global Melanoma Diagnostics and Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Melanoma Diagnostics and Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Melanoma Diagnostics and Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Diagnostic Center
        5.1.4 Medical Institution
        5.1.5 Others
    5.2 By Application - Global Melanoma Diagnostics and Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Melanoma Diagnostics and Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Melanoma Diagnostics and Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Melanoma Diagnostics and Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Melanoma Diagnostics and Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
        6.3.2 US Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.3.3 Canada Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
        6.4.2 Germany Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.3 France Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.5 Italy Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.6 Russia Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
        6.5.2 China Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.3 Japan Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.6 India Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.7.3 Israel Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
        6.7.5 UAE Melanoma Diagnostics and Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott
        7.1.1 Abbott Corporate Summary
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.1.4 Abbott Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Abbott Key News
    7.2 Agilent Technologies
        7.2.1 Agilent Technologies Corporate Summary
        7.2.2 Agilent Technologies Business Overview
        7.2.3 Agilent Technologies Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.2.4 Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Agilent Technologies Key News
    7.3 AstraZeneca
        7.3.1 AstraZeneca Corporate Summary
        7.3.2 AstraZeneca Business Overview
        7.3.3 AstraZeneca Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.3.4 AstraZeneca Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 AstraZeneca Key News
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Corporate Summary
        7.4.2 Bristol-Myers Squibb Business Overview
        7.4.3 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.4.4 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Bristol-Myers Squibb Key News
    7.5 Eli Lilly
        7.5.1 Eli Lilly Corporate Summary
        7.5.2 Eli Lilly Business Overview
        7.5.3 Eli Lilly Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.5.4 Eli Lilly Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Eli Lilly Key News
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Corporate Summary
        7.6.2 GlaxoSmithKline Business Overview
        7.6.3 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.6.4 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 GlaxoSmithKline Key News
    7.7 Merck
        7.7.1 Merck Corporate Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.7.4 Merck Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Merck Key News
    7.8 Novartis
        7.8.1 Novartis Corporate Summary
        7.8.2 Novartis Business Overview
        7.8.3 Novartis Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.8.4 Novartis Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Novartis Key News
    7.9 Pfizer
        7.9.1 Pfizer Corporate Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.9.4 Pfizer Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Pfizer Key News
    7.10 Qiagen
        7.10.1 Qiagen Corporate Summary
        7.10.2 Qiagen Business Overview
        7.10.3 Qiagen Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.10.4 Qiagen Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 Qiagen Key News
    7.11 Roche
        7.11.1 Roche Corporate Summary
        7.11.2 Roche Business Overview
        7.11.3 Roche Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.11.4 Roche Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.11.5 Roche Key News
    7.12 Sanofi
        7.12.1 Sanofi Corporate Summary
        7.12.2 Sanofi Business Overview
        7.12.3 Sanofi Melanoma Diagnostics and Therapeutics Major Product Offerings
        7.12.4 Sanofi Melanoma Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.12.5 Sanofi Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Melanoma Diagnostics and Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Melanoma Diagnostics and Therapeutics Market Drivers in Global Market
    Table 3. Melanoma Diagnostics and Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Melanoma Diagnostics and Therapeutics in Global Market
    Table 5. Top Melanoma Diagnostics and Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Melanoma Diagnostics and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Melanoma Diagnostics and Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Melanoma Diagnostics and Therapeutics Product Type
    Table 9. List of Global Tier 1 Melanoma Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Melanoma Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Melanoma Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Corporate Summary
    Table 31. Abbott Melanoma Diagnostics and Therapeutics Product Offerings
    Table 32. Abbott Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Agilent Technologies Corporate Summary
    Table 34. Agilent Technologies Melanoma Diagnostics and Therapeutics Product Offerings
    Table 35. Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. AstraZeneca Corporate Summary
    Table 37. AstraZeneca Melanoma Diagnostics and Therapeutics Product Offerings
    Table 38. AstraZeneca Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Bristol-Myers Squibb Corporate Summary
    Table 40. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Product Offerings
    Table 41. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. Eli Lilly Corporate Summary
    Table 43. Eli Lilly Melanoma Diagnostics and Therapeutics Product Offerings
    Table 44. Eli Lilly Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. GlaxoSmithKline Corporate Summary
    Table 46. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Product Offerings
    Table 47. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Merck Corporate Summary
    Table 49. Merck Melanoma Diagnostics and Therapeutics Product Offerings
    Table 50. Merck Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Novartis Corporate Summary
    Table 52. Novartis Melanoma Diagnostics and Therapeutics Product Offerings
    Table 53. Novartis Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Pfizer Corporate Summary
    Table 55. Pfizer Melanoma Diagnostics and Therapeutics Product Offerings
    Table 56. Pfizer Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Qiagen Corporate Summary
    Table 58. Qiagen Melanoma Diagnostics and Therapeutics Product Offerings
    Table 59. Qiagen Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 60. Roche Corporate Summary
    Table 61. Roche Melanoma Diagnostics and Therapeutics Product Offerings
    Table 62. Roche Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 63. Sanofi Corporate Summary
    Table 64. Sanofi Melanoma Diagnostics and Therapeutics Product Offerings
    Table 65. Sanofi Melanoma Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Melanoma Diagnostics and Therapeutics Segment by Type in 2021
    Figure 2. Melanoma Diagnostics and Therapeutics Segment by Application in 2021
    Figure 3. Global Melanoma Diagnostics and Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Melanoma Diagnostics and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Melanoma Diagnostics and Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Melanoma Diagnostics and Therapeutics Revenue in 2021
    Figure 8. By Type - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Melanoma Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Melanoma Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Agilent Technologies Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. AstraZeneca Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Eli Lilly Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. GlaxoSmithKline Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Merck Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Novartis Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Pfizer Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Qiagen Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Roche Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Sanofi Melanoma Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
68
Frequently Asked Questions
Melanoma Diagnostics and Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Melanoma Diagnostics and Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Melanoma Diagnostics and Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports